Product Details

Tessie 0.3 mg/ml Oral Solution for Dogs

• MA holder: Orion Corporation
• VM number: EU/2/21/276/001
• Territory: Northern Ireland
• Associated documents:
  • Available from EU Union Product Database
• Date of issue: 16/08/2021
• Authorisation route: Centralised
• Active substances:
  • Tasipimidine
• Target species:
  • Dogs
• Distribution category: POM-V